 is a disease that hits hard and fast, stripping people of their ability to move, speak, and eventually breathe){kind=link}
Amyotrophic lateral sclerosis (ALS) is a disease that hits hard and fast, stripping people of their ability to move, speak, and eventually breathe. Despite its devastating effects, the underlying causes of ALS have long remained elusive. However, a recent study published in Nature is beginning to unravel one of the key pieces of this puzzle: the role of a protein called SOD1.
ALS is marked by the gradual degeneration of motor neurons—the cells that control muscle movement. In about 20% of familial ALS (fALS) cases, a genetic mutation leads to the production of a faulty version of the SOD1 protein. Normally, SOD1 acts as a defense mechanism, protecting cells from damage. But when mutated, it seems to turn against the very cells it’s supposed to protect, leading to their degeneration.
The SOD1 protein functions by forming a pair with another SOD1 molecule, and these pairs, or dimers, rely on metal ions (zinc and copper) to stay stable. When this stability is lost, the protein can misfold, clump together, and ultimately harm the neurons.
To get a better look at how these proteins behave in the nervous system, scientists used a technique called native ambient mass spectrometry imaging (MSI). This advanced method allows them to see where different forms of the SOD1 protein are located in tissue samples from the brain and spinal cord of ALS model mice.
What’s unique about this approach is its ability to distinguish between the fully metal-bound SOD1 and the metal-deficient, potentially harmful forms. This detailed view is crucial for understanding how the misfolding process might lead to ALS.
The researchers discovered that in areas of the nervous system affected by ALS, the SOD1 protein often lacked its metal ions, making it more likely to misfold. These metal-deficient forms were particularly concentrated in regions of the brain and spinal cord associated with motor control—the same areas that are hardest hit by the disease. On the other hand, the fully metalated (and presumably more stable) SOD1 was more evenly distributed and didn’t show the same connection to areas of damage.
This suggests that the loss of metal ions in SOD1 might be a key factor in the development of ALS. Instead of the protein merely misfolding randomly, this study points to a specific process that leads to the degeneration of motor neurons.
While these findings don’t offer an immediate solution to ALS, they do provide a clearer picture of what might be going wrong at the molecular level. Understanding this process is a crucial step toward developing new treatments that could one day slow or stop the progression of the disease.